Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A dietary switch promotes sensory neuron-dependent cancer-associated cachexia.

Science (New York, N.Y.)·2026
Same author

Toll-like receptor 5 protects against murine lung fibrosis through reduced dysbiosis, and <i>TLR5</i> deficiency is associated with human IPF.

Science translational medicine·2026
Same author

What is new in pleural infections?

Breathe (Sheffield, England)·2026
Same author

Multi-omics to study chronic respiratory diseases and viral infections.

European respiratory review : an official journal of the European Respiratory Society·2026
Same author

BNT162b2 vaccine induces potent SARS-CoV-2 neutralising immunoglobulins in lung mucosa.

ERJ open research·2025
Same author

The ensemble approach: integrating microbiome therapeutics into our treatment of pneumonia.

The European respiratory journal·2025

Related Experiment Video

Updated: May 2, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.1K

Localized Microbial-Immunometabolic Interactions and Early Lung Cancer.

Fares Darawshy1,2,3, Leopoldo N Segal1

  • 1Division of Pulmonary and Critical Care Medicine, New York University Grossman School of Medicine, NYU Langone Health, New York, New York.

Cancer Prevention Research (Philadelphia, Pa.)
|May 1, 2026
PubMed
Summary
This summary is machine-generated.

The lower airway microbiome, particularly oral bacteria like Veillonella, Prevotella, and Streptococcus, promotes non-small cell lung cancer (NSCLC) development. Stearic acid produced by these bacteria drives inflammation and cancer growth.

More Related Videos

Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment
11:19

Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment

Published on: February 3, 2016

12.0K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

17.0K

Related Experiment Videos

Last Updated: May 2, 2026

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
07:39

The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues

Published on: June 16, 2018

9.1K
Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment
11:19

Ex vivo Live Imaging of Lung Metastasis and Their Microenvironment

Published on: February 3, 2016

12.0K
MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening
08:14

MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier MSC for Lung Cancer Screening

Published on: October 26, 2017

17.0K

Area of Science:

  • Microbiology
  • Oncology
  • Immunology

Background:

  • The lower airway microbiome's role in non-small cell lung cancer (NSCLC) is increasingly recognized.
  • Oral commensals are implicated in lung carcinogenesis, altering immune responses.

Purpose of the Study:

  • To investigate the microbial and metabolic landscape of the lower airways in early-stage NSCLC.
  • To understand the link between specific microbial taxa, metabolites, and oncogenic pathways.

Main Methods:

  • Integrative multiomic analysis of bronchoalveolar lavage fluid from tumor-affected and unaffected lung lobes.
  • Comparison of microbial composition and metabolite profiles within individual NSCLC patients.

Main Results:

  • Enrichment of Veillonella, Prevotella, and Streptococcus taxa in tumor-affected lung sites.
  • Increased levels of stearic acid (SA) in tumor-associated niches.
  • SA promotes pro-inflammatory cytokine secretion by macrophages, potentially driving neoplastic transformation.

Conclusions:

  • A localized microbial-immunometabolic niche exists in early-stage NSCLC.
  • Lung microbiome-driven metabolic reprogramming of innate immunity is an early event in tumorigenesis.
  • Findings suggest novel diagnostic and therapeutic strategies targeting the lung microbiome in NSCLC.